- Index
- 1 NOTE F1 Revenue and segment information
- 2 NOTE F2 Consolidated income statement by nature
- 3 NOTE F3 Revenue from non-core activities
- 4 NOTE F4 Other operating gains and losses
- 5 NOTE F5 Results from portfolio management and reassessments, legacy remediation and major litigations
- 6 NOTE F6 Net financial charges
- 7 NOTE F7 Income taxes
- 8 NOTE F8 Discontinued operations
- 9 NOTE F9 Profit for the year
- 10 NOTE F10 Earnings per share
In € million |
Notes |
2019 |
2018 |
Net sales |
10,244 |
10,257 |
|
Revenue from non-core activities |
983 |
1,042 |
|
Raw materials, utilities and consumables used |
|
(4,825) |
(5,344) |
Changes in inventories |
|
(151) |
165 |
Personnel expenses |
|
(2,308) |
(2,229) |
Wages and direct social benefits |
|
(1,672) |
(1,634) |
Employer's contribution for social insurance |
|
(304) |
(307) |
Pensions and insurance benefits |
|
(155) |
(105) |
Other personnel expenses |
|
(175) |
(182) |
Amortization, depreciation and impairment |
(1,906) |
(944) |
|
Other variable logistics expenses |
|
(716) |
(716) |
Other fixed expenses |
|
(1,037) |
(923) |
Addition and reversal of provisions (excluding employee benefit provisions) |
(50) |
(263) |
|
Operating lease expenses |
|
|
(101) |
M&A costs and gains and losses on disposals |
(13) |
(3) |
|
Earnings from associates and joint ventures |
95 |
44 |
|
EBIT |
|
316 |
986 |
Cost of borrowings |
(140) |
(131) |
|
Interest on loans and short term deposits |
15 |
13 |
|
Other gains and losses on net indebtedness |
(16) |
(1) |
|
Cost of discounting provisions |
(105) |
(77) |
|
Income from equity instruments measured at fair value through other comprehensive income |
|
4 |
|
Profit for the year before taxes |
|
74 |
791 |
Income taxes |
(153) |
(75) |
|
Profit/(loss) for the year from continuing operations |
|
(79) |
716 |
Profit for the year from discontinued operations |
236 |
201 |
|
Profit for the year |
157 |
917 |
|
attributable to: |
|
|
|
Solvay share |
|
118 |
877 |
non-controlling interests |
|
38 |
39 |